Our trails and trials in the subsarcolemmal cytoskeleton network and muscular dystrophy researches in the dystrophin era

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 86, Issue 8, 2010, Pages 798-821

  Ozawa, Eijiro ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Duchenne muscular dystrophy; Dystrophin; Dystrophin associated proteins; Dystrophin bolt; Sarcoglycanopathy; Transverse fixation system

Indexed keywords

ACTIN; DYSTROPHIN; LAMININ;

ANIMAL; BIOCHEMISTRY; BIOLOGICAL MODEL; CHEMISTRY; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; HISTORY; HUMAN; LIPID BILAYER; METABOLISM; MOLECULAR CLONING; MOUSE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; SARCOGLYCANOPATHY; SARCOLEMMA;

ACTINS; ANIMALS; BIOCHEMISTRY; CLONING, MOLECULAR; CYTOSKELETON; DYSTROPHIN; HISTORY, 20TH CENTURY; HUMANS; LAMININ; LIPID BILAYERS; MICE; MODELS, BIOLOGICAL; MUSCULAR DYSTROPHY, DUCHENNE; PROTEIN STRUCTURE, TERTIARY; SARCOGLYCANOPATHIES; SARCOLEMMA;

EID: 77958557373     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.86.798     Document Type: Review

References (102)

1. Gowers, W.R. (1879) Pseudo-hypertrophic muscular paralysis. Lancet 2, 1-2, 37-39, 73-75 and 113-116.
2. Erb, W. (1891) Dystrophia muscularis progressiva. Dtsch. Z. Nervenheilkd. 1, 13-94, 173-261.
3. Sibley, J.A. and Lehninger, A.L. (1949) Aldolase in serum and tissue of tumor bearing animals. J. Natl. Cancer Inst. 9, 303-309.
4. Ebashi, S., Toyokura, Y., Momoi, H. and Sugita, H. (1959) High creatine phosphokinase activity of sera of progressive muscular dystrophy. J. Biochem. 46, 103-104.
5. Engel, A.G. and Ozawa, E. (2004) Dystrophinopathies. In Myology 3rd ed. (eds. Engel, A.G. and Franzini-Armstrong, C). Vol. 2, McGraw-Hill, New York, pp. 961-1025.
6. Florence, J.M., Fox, P.T., Planer, G.J. and Brooke, M.H. (1985) Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology? Neurology 35, 758-761.
7. Imahori, K. (1980) Characterization of calcium-activated netral protease (CANP). In Muscular Dystrophy (ed. Ebashi, S.). University of Tokyo Press, Tokyo, pp. 253-264.
8. Koenig, M., Hoffman, E.P., Bertelson, C.J., Monaco, A.P., Feener, C. and Kunkel, L.M. (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517.
9. Koenig, M., Monaco, A.P. and Kunkel, L.M. (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeleton protein. Cell 53, 219-228.
10. Rybakova, I.N., Amann, K.J. and Ervasti, J.M. (1996) A new model for the interaction of dystrophin with F-actin. J. Cell Biol. 135, 661-672.
11. Love, D.R., Hill, D.F., Dickson, G., Spurr, N.K., Byth, B.C., Marsden, R.F. et al. (1989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339, 55-58.
12. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580.
13. Sugita, H., Arahata, K., Ishiguro, T., Suhara, Y., Tsukahara, T., Ishiura, S. et al. (1988) Negative immunostaining of Duchenne muscular dystrophy (DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA. Proc. Jpn. Acad. Ser. B 64, 37-39.
14. Arahata, K., Ishiura, S., Ishiguro, T., Tsukahara, T., Suhara, Y., Eguchi, C. et al. (1988) Immunos-taining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333, 861-863.
15. Craig, S.W. and Pardo, J.V. (1983) Gamma actin, spectrin, and intermedite filament proteins colocalize with vinculin at costameres, myofibril-to-sarcolemma attachment site. Cell Motil. 3, 449-462.
16. Wakayama, Y. and Shibuya, S. (1991) Gold-labelled dystrophin molecule in muscle plasmalemma of mdx control mice as seen by electron microscopy of deep etching replica. Acta Neuropathol. 82, 178-184.
17. Cullen, M.J., Walsh, J., Nicholson, L.V.B., Harris, J.B., Zubrzycka-Gaarn, E.E., Ray, P.N. et al. (1991) Immunogold labelling of dystrophin in human muscle, using an antibody to the last 17 amino acids of the C-terminus. Neuromuscul. Disord. 1, 113-119.
18. Watkins, S.C., Hoffman, E.P., Slayter, H.S. and Kunkel, L.M. (1988) Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333, 863-866.
19. Hoffman, E.P., Hudecki, M.S., Rosenberg, P.A., Pollina, C.M. and Kunkel, L.M. (1988) Cell and fiber-type distribution of dystrophin. Neuron 1, 411-420.
20. Hagiwara, Y., Yoshida, M., Nonaka, I. and Ozawa, E. (1989) Developmental expression of dystrophin on the plasma membrane. Protoplasma 151, 11-18.
21. Tanaka, H., Shimizu, T. and Ozawa, E. (1989) Expression of a dystrophin-like protein on the surface membrane of muscle cells in mdx mice. Proc. Jpn. Acad., Ser. B 65, 238-241.
22. Tanaka, H., Ishiguro, T., Eguchi, C., Saito, K. and Ozawa, E. (1991) Expression of a dystrophin-related protein associated with the skeletal muscle cell membrane. Histochemistry 96, 1-5.
23. Mizuno, Y., Nonaka, I., Hirai, S. and Ozawa, E. (1993) Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. J. Neurol. Sci. 119, 43-52.
24. Mizuno, Y., Yoshida, M., Nonaka, I., Hirai, S. and Ozawa, E. (1994) Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve 17, 206-216.
25. Campbell, K.P. and Kahl, S.D. (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338, 259-262.
26. Yoshida, M. and Ozawa, E. (1990) Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. 108, 748-752.
27. Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G. and Campbell, K.P. (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315-319.
28. Ibraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W. and Campbell, K.P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696-702.
29. Ervasti, J.M. and Campbell, K.P. (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121-1131.
30. Tinsley, J.M., Blake, D.J., Zuellig, R.A. and Davies, K.E. (1994) Increasing complexity of the dystrophin-associated protein complex. Proc. Natl. Acad. Sci. USA 91, 8307-8313.
31. Yamamoto, H., Hagiwara, Y., Mizuno, Y., Yoshida, M. and Ozawa, E. (1993) Heterogeneity of dystrophin-associated proteins. J. Biochem. 114, 132-139.
32. Yoshida, M., Hama, H., Ishikawa-Sakurai, M., Imamura, M., Mizuno, Y., Araishi, K. et al. (2000) Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum. Mol. Genet. 9, 1033-1040.
33. Peters, M.F., Adams, M.E. and Froehner, S.C. (1997) Differential association of syntrophin pairs with the dystrophin complex. J. Cell Biol. 138, 81-93.
34. Crosbie, R.H., Heighway, J., Venzke, D.P., Lee, J.C. and Campbell, K.P. (1997) Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J. Biol. Chem. 272, 31221-31224.
35. Levine, B.A., Moir, A.J., Patchell, V.B. and Perry, S.V. (1992) Binding sites involved in the interaction of actin with the N-terminal region of dystrophin. FEBS Lett. 298, 44-48.
36. Brenman, J.E., Chao, D.S., Gee, S.H., McGee, A.M., Craven, S.E., Santillano, D.R. et al. (1996) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 84, 757-767.
37. Ozawa, E. (2004) The muscle fiber cytoskeleton: The dystrophin sytem. In Myology 3rd ed. (eds. Engel, A.G. and Franzini-Armstrong). Vol. 1, McGraw-Hill, New York, pp. 455-470.
38. Sadoulet-Puccio, H.M., Rajala, M. and Kunkel, L.M. (1997) Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc. Natl. Acad. Sci. USA 94, 12413-12418.
39. Yoshida, M., Suzuki, A., Shimizu, T. and Ozawa, E. (1992) Proteinase-sensitive sites on isolated rabbit dystrophin. J. Biochem. 112, 433-439.
40. Suzuki, A., Yoshida, M., Yamamoto, H. and Ozawa, E. (1992) Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett. 308, 154-160.
41. Koenig, M., Beggs, A.H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T. et al. (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 45, 498-506.
42. Suzuki, A., Yoshida, M., Hayashi, K., Mizuno, Y., Hagiwara, Y. and Ozawa, E. (1994) Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur. J. Biochem. 220, 283-292.
43. Jung, D., Yang, B., Meyer, J., Chamberlain, J. and Campbell, K.P. (1995) Identification and characterization of the dystrophin anchoring site of β-dystroglycan. J. Biol. Chem. 270, 27305-27310.
44. Ishikawa-Sakurai, M., Yoshida, M., Imamura, M., Davies, K.E. and Ozawa, E. (2004) ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to β-dystroglycan. Hum. Mol. Genet. 13, 693-702.
45. Yuasa, K., Miyagoe, Y., Yamamoto, K., Nabeshima, Y., Dickson, G. and Takeda, S. (1998) Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs. FEBS Lett. 425, 329-336.
46. Rafael, J.A., Cox, G.A., Corrado, K., Jung, D., Campbell, K.P. and Chamberlain, J.S. (1996) Forced expression of dystrophin deletion constructs reveals structure-function correlations. J. Cell Biol. 134, 93-102.
47. Monaco, A.P., Bertelson, C.J., Liechti-Gallati, S., Moser, H. and Kunkel, L.M. (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2, 90-95.
48. Tuffery-Giraud, S., Beroud, C., Leturcq, F., Yaou, R.B., Hamroun, D., Michel-Calemard, L. et al. (2009) Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum. Mutat. 30, 934-945.
49. Malhotra, S.B., Hart, K.A., Klamut, H.J., Thomas, N.S., Bodrug, S.E., Burghes, A.H. et al. (1988) Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242, 755-759.
50. Ozawa, E., Yoshida, M., Suzuki, A., Mizuno, Y., Hagiwara, Y. and Noguchi, S. (1995) Dystrophin-associated proteins in muscular dystrophy. Hum. Mol. Genet. 4, 1711-1716.
51. Ozawa, E. (2006) The functional biology of dystrophin: structural components and the pathogenesis of Duchenne muscular dystrophy. In Duchenne Muscular Dystrophy (eds. Chamberlain, J.S. and Rando, T.A.). Taylor & Francis, New York, pp. 21-53.
52. Yoshida, M., Suzuki, A., Yamamoto, H., Noguchi, S., Mizuno, Y. and Ozawa, E. (1994) Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl β-D-glucoside. Eur. J. Biochem. 222, 1055-1061.
53. Ozawa, E., Noguchi, S., Mizuno, Y., Hagiwara, Y. and Yoshida, M. (1998) From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve 21, 421-438.
54. Nigro, V., Piluso, G., Belsito, A., Politano, L., Puca, A.A., Papparella, S. et al. (1996) Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35kDa glycoprotein. Hum. Mol. Genet. 5, 1179-1186.
55. Yoshida, M., Noguchi, S., Wakabayashi, E., Piluso, G., Belsito, A., Nigro, V. et al. (1997) The fourth component of the sarcoglycan complex. FEBS Lett. 403, 143-148.
56. Ozawa, E., Mizuno, Y., Hagiwara, Y., Sasaoka, T. and Yoshida, M. (2005) Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 32, 563-576.
57. Suzuki, A., Yoshida, M. and Ozawa, E. (1995) Mammalian α1- and β1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus. J. Cell Biol. 128, 373-381.
58. Ahn, A.H. and Kunkel, L.M. (1995) Syntrophin binds to an alternatively spliced exon of dystro-phin. J. Cell Biol. 128, 363-371.
59. Ozawa, E., Nishino, I. and Nonaka, I. (2001) Sarcolemmopathy: muscular dystrophies with cell membrane defects. Brain Pathol. 11, 218-230.
60. Rafael, J.A., Tinsley, J.M., Potter, A.C., Deconinck, A.E. and Davies, K.E. (1998) Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat. Genet. 19, 79-82.
61. Mizuno, Y., Noguchi, S., Yamamoto, H., Yoshida, M., Suzuki, A., Hagiwara, Y. et al. (1994) Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy muscle. Biochem. Biophys. Res. Commun. 203, 979-983.
62. Chan, Y. and Kunkel, L.M. (1997) In vitro ex-pressed dystrophin fragments do not associate with each other. FEBS Lett. 410, 153-159.
63. Rybakova, I.N. and Ervasti, J.M. (1997) Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J. Biol. Chem. 272, 28771-28778.
64. Matsumura, K., Tome, F.M., Collin, H., Azibi, K., Chaouch, M., Kaplan, J.C. et al. (1992) Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature 359, 320-322.
65. Ben Othmane, K., Ben Hamida, M., Pericak-Vance, M.A., Ben Hamida, C., Blel, S., Carter, S.C. et al. (1992) Linkage of Tunisian autosomal recessive Duchenne-like muscular dystrophy to the pericentromeric region of chromosome 13q. Nat. Genet. 2, 315-317.
66. Passos-Bueno, M.R., Oliveira, J.R., Bakker, E., Anderson, R.D., Marie, S.K., Vainzof, M. et al. (1993) Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysis. Hum. Mol. Genet. 2, 1945-1947.
67. Roberds, S.L., Leturcq, F., Allamand, V., Piccolo, F., Jeanpierre, M., Anderson, R.D. et al. (1994) Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 78, 625-633.
68. Bonnemann, C.G., Modi, R., Noguchi, S., Mizuno, Y., Yoshida, M., Gussoni, E. et al. (1995) β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat. Genet. 11, 266-273.
69. Lim, L.E., Duclos, F., Broux, O., Bourg, N., Sunada, Y., Allamand, V. et al. (1995) β-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat. Genet. 11, 257-265.
70. Noguchi, S., McNally, E.M., Ben Othmane, K., Hagiwara, Y., Mizuno, Y., Yoshida, M. et al. (1995) Mutations in the Dystrophin-associated protein-sarcoglycan in chromosome 13 muscular dystrophy. Science 270, 819-822.
71. Passos-Bueno, M.R., Moreira, E.S., Vainzof, M., Marie, S.K. and Zatz, M. (1996) Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR LGMD) maps a sixth form to 5q33-34 (LGMD 2F) and indicates that there is at least one more subtype of AR LGMD. Hum. Mol. Genet. 5, 815-820.
72. Nigro, V., de Sa Moreira, E., Piluso, G., Vainzof, M., Belsito, A., Politano, L. et al. (1996) Autosomal recessive limb-girdle muscular dystrophy, LGMD 2F, is caused by a mutation in the δ-sarcoglycan gene. Nat. Genet. 14, 195-198.
73. Vainzof, M., Passos-Bueno, M.R., Canovas, M., Moreira, E.S., Pavanello, R.C., Marie, S.K. et al. (1996) The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum. Mol. Genet. 5, 1963-1969.
74. Noguchi, S., Wakabayashi, E., Imamura, M., Yoshida, M. and Ozawa, E. (1999) Developmental expression of sarcoglycan gene products in cultured myocytes. Biochem. Biophys. Res. Commun. 262, 88-93.
75. Wakabayashi-Takai, E., Noguchi, S. and Ozawa, E. (2001) Identification of myogenesis-dependent transcriptional enhancers in promoter region of mouse γ-sarcoglycan gene. Eur. J. Biochem. 268, 948-957.
76. Noguchi, S., Wakabayashi, E., Imamura, M., Yoshida, M. and Ozawa, E. (2000) Formation of sarcoglycan complex with differentiation in cultured myocytes. Eur. J. Biochem. 267, 640-648.
77. Sakamoto, A., Ono, K., Abe, M., Jasmin, G., Eki, T., Murakami, Y. et al. (1997) Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystro-phin-associated glycoprotein complex. Proc. Natl. Acad. Sci. USA 94, 13873-13878.
78. Araishi, K., Sasaoka, T., Imamura, M., Noguchi, S., Hama, H., Wakabayashi, E. et al. (1999) Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in β-sarcoglycan-deficient mice. Hum. Mol. Genet. 8, 1589-1598.
79. Sasaoka, T., Imamura, M., Araishi, K., Noguchi, S., Mizuno, Y., Takagoshi, N. et al. (2003) Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in γ-sarcoglycan-deficient mice. Neuromuscul. Disord. 13, 193-206.
80. Hagiwara, Y., Sasaoka, T., Araishi, K., Imamura, M., Yorifuji, H., Nonaka, I. et al. (2000) Caveolin-3 deficiency causes muscle degeneration in mice. Hum. Mol. Genet. 9, 3047-3054.
81. Ozawa, E., Hagiwara, Y. and Yoshida, M. (1999) Creatine kinase, cell membrane and Duchenne muscular dystrophy. Mol. Cell. Biochem. 190, 143-151.
82. Ozawa, E. and Nonaka, I. (2002) Limb-girdle muscular dystrophy and related disorders. In Neuromuscular Disorders in Clinical Practice (eds. Katirji, B., Kaminski, H.J. et al.). Butter-worth-Heinemann, Boston, pp. 1049-1071.
83. Lazarides, E. (1980) Intermediate filaments as mechanical integrators of cellular space. Nature 283, 249-256.
84. Granger, B.L. and Lazarides, E. (1979) Desmin and vimantin coexist at the periohery of the myofibril Z disc. Cell 18, 1053-1063.
85. Shear, C.R. and Bloch, R.J. (1985) Vinculin in subsarcolemmal densities in chicken skeletal muscle: localization and relationship to intra-cellular and extracellular structures. J. Cell Biol. 101, 240-256.
86. Elliott, G.F. (1963) A small-angle optically focusing X-ray diffraction camera in biological research. II. J. Ultrastruct. Res. 9, 171-176.
87. Ohtsuki, I. and Ozawa, E. (1977) Difference in sapanin sensitivity between myotubes and mono-nucleated cells from chick breast muscle. Cell Struct. Funct. 2, 367-370.
88. Matsubara, I., Umazume, Y. and Yagi, N. (1984) Lateral shrinkage of the myofilament lattice in chemically skinned muscle during contraction. Adv. Exp. Med. Biol. 170, 711-720.
89. Noakes, T.D. (1987) Effect of exercise on serum activities in humans. Sports Med. 4, 245-267.
90. Cai, C., Masumiya, H., Weisleder, N., Matsuda, N., Nishi, M., Hwang, M. et al. (2009) MG53 nucleates assembly of cell membrane repair machinery. Nat. Cell Biol. 11, 56-64.
91. Hutter, O.F., Burton, F.L. and Bovell, D.L. (1991) Mechanical properties of normal and mdx mouse sarcolemma: bearing on function of dystrophin. J. Muscle Res. Cell Motil. 12, 585-589.
92. Iwata, Y., Nakamura, H., Mizuno, Y., Yoshida, M., Ozawa, E. and Shigekawa, M. (1993) Defective association of dystrophin with sarcolemmal glycoproteins in the cardiomyopathic hamster heart. FEBS Lett. 329, 227-231.
93. Chiba, A., Matsumura, K., Yamada, H., Inazu, T., Shimizu, T., Kusunoki, S. et al. (1997) Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. J. Biol. Chem. 272, 2156-2162.
94. Endo, T. (2007) Dystroglycans. In Comprehensive Glycoscience. From Chemistry to System Biology (eds. Kamerling, J.P., Boons, G.-J. et al.). Elsevier, Oxford, pp. 285-296.
95. Tome, T. (1999) The saga of congenital muscular dystrophy. Neuropediatrics 30, 55-65.
96. Hayashi, Y.K., Ishihara, T., Domen, K., Hori, H. and Arahata, K. (1997) A benign allelic form of laminin α2 chain deficient muscular dystrophy. Lancet 349, 1147.
97. Sher, R.B., Aoyama, C., Huebsch, K.A., Ji, S., Kerner, J., Yang, Y. et al. (2006) A rostrocaudal muscular dystrophy caused by a defect in choline kinase b, the first enzyme in phosphatidylcholine biosynthesis. J. Biol. Chem. 281, 4938-4948.
98. Ebashi, S. and Endo, M. (1968) Calcium ion and muscle contraction. Prog. Biophys. Mol. Biol. 18, 123-183.
99. 2+-permeable growth factor regulated channel. J. Cell Biol. 161, 957-967.
100. England, S.B., Nicholson, L.V., Johnson, M.A., Forrest, S.M., Love, D.R., Zubrzycka-Gaarn, E.E. et al. (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343, 180-182.
101. Harper, S.Q., Hauser, M.A., DelloRusso, C., Duan, D., Crawford, R.W., Phelps, S.F. et al. (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 8, 253-261.
102. Matsuo, M., Masumura, T., Nakajima, T., Kitoh, Y., Takumi, T., Nishio, H. et al. (1990) A very small frame-shifting deletion within exon 19 of the Duchenne muscular dystrophy gene. Biochem. Biophys. Res. Commun. 170, 963-967.